The 5 Best Penny Stocks to Buy Right Now

You can start trading penny stocks, which are defined as small shares that trade for less than one dollar and are known for their volatility if you’re up for a challenge. The biggest penny stock movers lay in the tables below.  Check back daily for updates, and sign up for our newsletter or browser push alerts for daily trades.


These ideas are not stock picks. Benzinga’s highlighting of these stocks does not indicate a suggestion to buy or sell a stock.

1. vTv Therapeutics (VTVT)

<center>[finviz ticker=VTVT]</center>

Shares rallied more than 200 percent on December 28, 2018 following news the company exercised its right for a shareholder to purchase about 815,000 shares at $1.84/share. At the time the news was announced, shares were trading around a dollar. The stock has remained just below the $3 level since then, a level which appears to have served as resistance back in October of 2018.

Editor’s Note: This $3 stock might be the biggest winner of 2019

It has hundreds of billions in revenue, is a leader in cutting edge technology, has tens of thousands in unbreakable patents, pays an enormous dividend, and is on the verge of dozens of blockbuster announcements that will send could send the stock soaring higher and higher… Click here to see what it is

2. Axsome Therapeutics (AXSM)

<center>[finviz ticker=AXSM]</center>

One of the most frequently searched tickers on the Benzinga Pro real-time news platform to start 2019, Axsome shares have also been one of the top penny-stock performers of the year, up about 215 percent. The stock rallied more than 200 percent on Friday, January 4 after the company disclosed a Phase 2 trial for its major depressive disorder treatment achieved its primary endpoint. Despite news of a 2.8 million share common stock offering the day after the Phase 2 news, shares of Axsome are only down about 14 percent from recent highs.

3. Alliqua Biomedial (ALQA)

<center>[finviz ticker=ALQA]</center>

A popular low-float, momentum stock at the end of November and heading into December. Since news of a spin off and merger deal for its Contract Manufacturing unit and the subsequent 200 percent rally, shares are down nearly 60 percent from highs, but still up 36 percent since the M&A news.

4. Adial Pharma (ADIL)

<center>[finviz ticker=ADIL]</center>

The stock has consistently set higher lows since breaking above the $2 level back in November. “Higher lows” refers to a technicians translation of a chart suggesting shares haven’t gone as low as the last time the stock price was near a similar level. Some technicians will use the identifying of higher lows or higher highs as an indication the current trend will continue; however, the “higher highs” case has not played out as shares are down from the end-of-December high of $7.45.

5. BioXcel Therapeutics (BTAI)

<center>[finviz ticker=BTAI]</center>

Shares are flirting with the $5 level after a somewhat slower — for a penny stock – drift higher after the company disclosed its BXCL501 candidate for acute treatment of agitation received FDA Fast Track Designation.


As state above, these stocks are not stock picks and are not recommendations to buy or sell a stock. Rather, these ideas should be viewed as potential opportunities for elevated levels of volatility and trader interest and thus increased liquidity. These stocks can be opportunities for traders who already have an existing strategy to play sub-$5 stocks. Penny stocks can be extremely dangerous for a number of reasons, including the major swings in percent a small dollar/cent move can create, decreased liquidity when interest fades and decreased transparency into operations. Penny-stock trading is not for beginners. Benzinga does not recommend trading or investing in low-priced stocks if you haven’t had at least a couple years of experience in the stock market.